Table 2. CD4+ lymphocytes, absolute lymphocyte count and absolute neutrophil counts before and after Imatinib Mesylate therapy

	CD4+ Lymphocytes (/µL)		Absolute Lymphocyte Count (/µL)		Absolute Neutrophil Count (/µL)
Patient	Baseline	After imatinib	Baseline	After imatinib	Baseline	After imatinib
1	1,008	515	14,500	660	14,500	2,700
2	1,063	536	21,900	980	19,710	3,280
3	3,269	1,254	12,000	4,758	288,000	3,042
4	542	628	1,922	3,245	1,478	2,655
5	2,944	1,603	44,775	4,278	452,725	2,622
6	1,162	524	1242	1512	1458	3888
7	1,941	631	30,613	2,320	247,687	1,680
8	649	600	2,277	2,442	1,023	1,258
9	2,027	1,050	22,121	1,656	178,979	744
10	3,141	1,028	49,362	5,115	210,438	11,385